Choice critical of analgesic pricing and claims

Manufacturers have hit back after news reports claimed Australian consumers were the victims of misleading claims and overpricing on over-the-counter analgesics.

Consumer watchdog, Choice, said Australians were paying too much for supposedly “premium versions” of popular analgesics such as Panadol and Nurofen.